How is your cold chain data fitting into your digitalization strategy? 

Temperature data holds the key to proving quality compliance. However, it’s just one piece of the puzzle. Combine it effectively in your evolving IoT supply chain, and the world is your oyster. Supply chain visibility and cost-effective operations are at your fingertips.

ELPRO is a global partner to biopharma for the past 30+ years.

If investing for the long-haul IoT future, working with a trusted, experienced monitoring partner is the safest way to go.

WATCH THE VIDEO HERE

Digital transformation is a journey.

The future holds exciting promises.

But today – there are many challenges.

Problems piecing together data from different sites and lane segments

Inefficient processes in evaluating temperature excursions

Data in disparate silos creating inefficient decision making

Lack of visibility into how sites and partners are in compliance with your SOPs

GET IN TOUCH WITH US TODAY!

ELPRO steers you on the path toward process automation and supply chain 4.0 

Intelligent software

AI isn’t giving us all the answers yet. Instead, we need to build the data, to make informative decisions.

ELPRO liberoMANAGER is the most advanced temperature monitoring database. It can automate workflows and product release. Or go the next step, to integrate with your ERP and QMS, to continue working toward complete supply chain digitalization.

Sustainable Real-time Tracking

Trends come and go, technology evolves. 
That’s why, when ELPRO creates a new solution, you can be sure it’s with great consideration. 

The new LIBERO Gx for real-time monitoring is based on LPWAN, Cat M1 (NB-IoT) to ensure lower power consumption and lower cost. 

This sustainable technology for the long-term future offers better network coverage and longer transportation duration due to longevity of device operations. Users receive immediate, clear information from the device display, making it the most user-friendly device.

Contact us

Take a deep dive: Free Whitepaper

Last Miles & Clinical Supply

Direct-to-Patient distribution has changed the supply chain indefinitely. Supply into commercial and clinical last miles has brought the patient closer than ever before.

LIBERO ITS is a unit-level long-term indicator thin and durable to make it from point of manufacture, to a patient's refrigerator, or on a clinical kit to patient administration. Smart enough to record deviations, create reports, and manage individual stability budgets. The LIBERO ITS delivers your temperature data in a format that be assessed in software or a database.

watch the LIBERO ITS Video here

Source: Leading Minds Seminar Amsterdam: November 13 – 14 2019

Go to article: Home | Pause for thoughtGo to article: In this issueGo to article: NSFGo to article: ContentsGo to article: Datwyler Company Insight Go to article: DatwylerGo to article: NewsGo to article: BaxterGo to article: Covid-19 executive briefing by GlobalDataGo to article: ELPRO Monitoring SolutionsGo to article: Abivax’s ABX464 enticing in theory for Covid-19 but mechanism, trial design issues belie potential for successGo to article: Abiomed’s Impella receives FDA Emergency Use Authorization during Covid-19Go to article: FargoGo to article: Disruptions to global oncology trials have fallen to a three-month lowGo to article: MimotopesGo to article: AstraZeneca/Oxford University and CanSino publish promising Covid-19 vaccine cliGo to article: Biotech IPO valuation relies on data to enter capital markets during Covid-19 paGo to article: Nelson LabsGo to article: The pharma industry briefingGo to article: Pfeiffer VacuumGo to article: A century of cultures: celebrating the world’s oldest lab culture collectionGo to article: SkyepharmaGo to article: Gut feeling: exploring the therapeutic potential of the gut-brain axisGo to article: OptelGo to article: Crabby concoctions: why pharma’s thirst for crustacean blood is up for debateGo to article: Air FranceGo to article: Debunking myths about puberty blockers for transgender childrenGo to article: MicronovaGo to article: Hiring from home: pharma recruitment in the age of Covid-19 Go to article: Nipro PharmapackagingGo to article: Q&A: breaking new ground in pharma packaging with HoneywellGo to article: WipotecGo to article: Treatment-resistant rare diseases: exploring landmark drug approvals in 2020Go to article: VEGA Company Insight Go to article: VEGA AustraliaGo to article: Modernising pharma patents: can AI be an inventor?Go to article: ILC Dover Go to article: Boosting agility to accelerate project timescales Go to article: Scandinavian HealthGo to article: Doing the right thing: the enhanced case for complianceGo to article: Deals in brief powered by GlobalDataGo to article: The key list powered by GlobalDataGo to article: Global markets and indices powered by GlobalDataGo to article: Macro-economic indicators (1 of 2) powered by GlobalDataGo to article: Macro-economic indicators (2 of 2) powered by GlobalDataGo to article: EventsGo to article: Next issue